Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Haemophilia B”

79 trials

Showing 20 of 79 results

Post-approval studies (Phase 4)Study completedNCT00092976
What this trial is testing

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer 15
Large-scale testing (Phase 3)Study completedNCT03569891
What this trial is testing

HOPE-B: Trial of AMT-061 in Severe or Moderately Severe Hemophilia B Patients

Who this might be right for
Hemophilia B
CSL Behring 67
Not applicableStudy completedNCT00936845
What this trial is testing

Females With Severe or Moderate Hemophilia A or B: A Multi-Center Study

Who this might be right for
Hemophilia AHemophilia B
Weill Medical College of Cornell University 22
Large-scale testing (Phase 3)Study completedNCT03417245
What this trial is testing

Fitusiran (ALN-AT3SC) in Severe Hemophilia A and B Patients Without Inhibitors

Who this might be right for
Hemophilia AHemophilia B
Genzyme, a Sanofi Company 120
Large-scale testing (Phase 3)Study completedNCT00037557
What this trial is testing

Study Evaluating rFIX; BeneFIX in Severe Hemophilia B

Who this might be right for
Hemophilia B
Wyeth is now a wholly owned subsidiary of Pfizer 20
Large-scale testing (Phase 3)Study completedNCT02250560
What this trial is testing

Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Undergoing Major Surgery.

Who this might be right for
Haemophilia B
Bio Products Laboratory
Large-scale testing (Phase 3)Study completedNCT00364182
What this trial is testing

Study Comparing On-Demand Treatment With Two Prophylaxis Regimens Of BeneFIX In Patients With Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 50
Not applicableStudy completedNCT00195221
What this trial is testing

Study to Describe the Allergic Reactions to Factor IX in Patients With Hemophilia B

Who this might be right for
Hemophilia BAllergic Reactions
Wyeth is now a wholly owned subsidiary of Pfizer 166
Large-scale testing (Phase 3)Study completedNCT01488994
What this trial is testing

BAX 326 Pediatric Study

Who this might be right for
Hemophilia B
Baxalta now part of Shire 23
Large-scale testing (Phase 3)WithdrawnNCT02048111
What this trial is testing

Study of Recombinant Factor IX Product, IB1001, in Previously Treated Subjects With Hemophilia B

Who this might be right for
Hemophilia B
Cangene Corporation
Large-scale testing (Phase 3)Study completedNCT03587116
What this trial is testing

Evaluate Prospective Efficacy and Safety Data of Current FIX Prophylaxis Replacement Therapy in Adult Hemophilia B Subjects (FIX:C≤2%) or Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Subjects (FVIII:C≤1%)

Who this might be right for
Hemophilia BHemophilia A
Pfizer 212
Early research (Phase 1)Study completedNCT02035605
What this trial is testing

An Investigational Drug, ALN-AT3SC, in Healthy Volunteers and Hemophilia A or B Patients

Who this might be right for
Hemophilia AHemophilia B
Sanofi 51
Large-scale testing (Phase 3)Study completedNCT02263469
What this trial is testing

Investigate the Safety and Efficacy of Replenine®-VF in Haemophilia B Patients Under the Age of 6 Years

Who this might be right for
Haemophilia B
Bio Products Laboratory
Testing effectiveness (Phase 2)Study completedNCT03588299
What this trial is testing

Study to Test the Safety and How Well Patients With Severe Hemophilia A Respond to Treatment With BAY 2599023 (DTX 201), a Drug Therapy That Delivers a Healthy Version of the Defective Factor VIII Gene Into the Nucleus of Liver Cells Using an Altered, Non-infectious Virus (AAV) as a "Shuttle"

Who this might be right for
Hemophilia A
Bayer 11
Not applicableStudy completedNCT05617209
What this trial is testing

In Vitro Correction of Thrombin Generation by Concizumab (Anti-TFPI) for Severe Hemophilia Patients

Who this might be right for
Hemophilia
Centre Hospitalier Universitaire de Saint Etienne 20
Not applicableStudy completedNCT04590950
What this trial is testing

Dosage and PD Study of Eftrenonacog-alfa

Who this might be right for
Severe Haemophilia B
Assistance Publique - Hôpitaux de Paris 15
Large-scale testing (Phase 3)Study completedNCT01335061
What this trial is testing

Study To Compare On-Demand Treatment To A Prophylaxis Regimen Of BeneFIX In Subjects With Moderately Severe to Severe Hemophilia B

Who this might be right for
Hemophilia B
Pfizer 25
Testing effectiveness (Phase 2)Study completedNCT03363321
What this trial is testing

PF-06741086 Long-term Treatment in Severe Hemophilia

Who this might be right for
Hemophilia A or B
Pfizer 20
Testing effectiveness (Phase 2)Study completedNCT02974855
What this trial is testing

PF-06741086 Multiple Dose Study in Severe Hemophilia

Who this might be right for
Hemophilia A or B
Pfizer 27
Large-scale testing (Phase 3)Study completedNCT01027364
What this trial is testing

Study of Recombinant Factor IX Fc Fusion Protein (rFIXFc) in Participants With Hemophilia B

Who this might be right for
Severe Hemophilia B
Bioverativ Therapeutics Inc. 123
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation